Q linea AB (QLINEA)

Currency in SEK
17.00
+0.50(+3.03%)
Closed·
Advertisement
QLINEA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.2517.00
52 wk Range
14.5557.80
Key Statistics
Prev. Close
17
Open
16.7
Day's Range
16.25-17
52 wk Range
14.55-57.8
Volume
7.37K
Average Volume (3m)
9.05K
1-Year Change
-65.1639%
Book Value / Share
14.5
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
QLINEA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Q linea AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Q linea AB Earnings Call Summary for Q2/2026

  • Q-linea narrowed Q2 2026 operating loss to SEK -31.3M from SEK -47.4M YoY; net sales rose 200% to SEK 1.5M; stock gained 6.8% in premarket.
  • Company completed restructuring, consolidated to single Swedish site; ended quarter with SEK 187M cash and 24 contracted ASTar instruments vs. 12 YoY.
  • FDA approved expanded ASTar menu now fully rolled out to U.S. customers; isolate non-blood test launch remains on track for Q3 2026.
  • Management expects monthly operating expenses below SEK 11M in H2 2026; U.S. growth to come primarily from new contracts, not existing site utilization.
  • Revenue remains minimal despite 200% growth; consumable sales per instrument declined YoY to SEK 266K, signaling potential utilization challenges.
Last Updated: 10/07/2026, 12:38
Read Full Transcript

Earnings

Latest Release
10/07/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / 16.9M
EPS Revisions
Last 90 days

Q linea (QLINEA) Income Statement & Profits

Compare QLINEA to Peers and Sector

Metrics to compare
QLINEA
Peers
Sector
Relationship
P/E Ratio
−2.1x−1.7x−0.4x
PEG Ratio
0.1334.390.00
Price/Book
1.2x2.4x2.6x
Price / LTM Sales
22.3x3.0x2.9x
Upside (Analyst Target)
203.0%11.5%56.8%
Fair Value Upside
Unlock12.7%8.9%Unlock

Q-linea AB (publ) engages in the manufacturing and sale of instruments and consumables diagnose and treat infectious diseases in the United Kingdom, the United States, France, the Middle East, Belgium, Italy, and Finland. It offers ASTar, an antimicrobial susceptibility testing (AST) technology used in the treatment of bloodstream infections and sepsis; and ASTar BC G- Kit which contains two disposables, including a sample preparation cartridge and an AST disc, used with the Frozen insert. The company also develops Podler, a portable blood culture technology. It serves physicians, hospitals, laboratories, healthcare payers, and the medical profession. The company was incorporated in 2007 and is headquartered in Uppsala, Sweden.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
675.000.00%11.14K
Other Institutional Investors
10.80M57.02%178.28M
Public Companies & Retail Investors
8.14M42.97%134.36M
Total
18.95M100.00%312.65M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Investment AB Öresund (publ)29.87%5,660,74293,402
Nexttobe AB14.16%2,682,71344,265

FAQ

What Is the Q linea (Stockholm: QLINEA) Share Price Today?

The Q linea stock price today is 17.00 SEK.

What Stock Exchange Does Q linea (QLINEA) Trade On?

Q linea is listed and trades on the Stockholm Stock Exchange.

What Is the Ticker (Stock Symbol) for Q linea?

The stock symbol (also called a 'ticker') for Q linea is "QLINEA."

What Is the Current Q linea Market Capitalisation?

As of today, Q linea (Stockholm: QLINEA) market cap is 322.13M SEK.

What Is Q linea's (QLINEA) Earnings Per Share (TTM)?

The Q linea EPS is currently -22.91 (Trailing Twelve Months).

When Is the Next Q linea Earnings Date?

Q linea's next earnings report will be released on 30/10/2026.

Is QLINEA a Buy or Sell From a Technical Analyst Perspective?

Based on today's Q linea moving averages and other technical indicators, the daily buy/sell signal for QLINEA stock is Sell.

How Many Times Has Q linea Stock Split?

Q linea has split 1 times. (See the QLINEA stock split history page for full effective split date and price information.)

How Many Employees Does Q linea Have?

Q linea has 70 employees, based on their latest Companies House report.

What is the current trading status of Q linea (Stockholm: QLINEA)?

As of 28/07/2026, Q linea (QLINEA) is trading at a share price of 17.00 SEK, with a previous close of 17.00 SEK. The stock has fluctuated within a day range of 16.25 SEK to 17.00 SEK, while its 52-week range spans from 14.55 SEK to 57.80 SEK.

What Is Q linea (QLINEA) Price Target According to Analysts?

The average 12-month price target for Q linea is 50.00 SEK, with a high estimate of 50 SEK and a low estimate of 50 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +194.12% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.